Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

The latest car news, videos and expert reviews, from Cars.com's independent automotive journalists A low purchase price is only the start to finding a truly affordable car. Their spectacular fuel ...

As Chief Information Security Officers (CISOs) and security leaders, you are tasked with safeguarding your organization in an ...